Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients Clinical research trials and Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients. Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients clinical trial. Subjects frequently obtain the most expert healthcare possible for their Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients



Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

For Condition: Breast Cancer,Breast Neoplasm
Status: No longer recruiting
Sponsor(s): Warren G Magnuson Clinical Center (CC) ,
Synopsis: This research study is designed to work in cooperation with another study being conducted by the National Cancer Institute. The National Cancer Institute (NCI) is studying the effects of a drug called raloxifene on premenopausal women believed to have a high risk of developing breast cancer (98-C-0123). In this study, researchers are interested in learning about the effects of raloxifene on the uterus and ovaries of the women participating in the NCI study. To do this researchers plan to conduct ultrasounds on the patients enrolled in the NCI study. In addition researchers plan to take samples of the lining of the uterus in these patients (endometrial biopsy) if found to be necessary. The purpose of this study is to determine the reproductive effects of raloxifene on women who have normal functioning ovaries by taking ultrasounds of the ovaries and lining of the uterus (endometrium).
Details: Raloxifene is a selective estrogen receptor-modulating agent that has been recently approved by the FDA for the treatment of osteoporosis in postmenopausal patients. A phase II trial evaluating the safety and efficacy of raloxifene in premenopausal patients at high risk for developing breast cancer has been recently approved by the IRB (98-C-0123). In this protocol, for assessment of the effects of raloxifene on the endometrium and ovaries, patients are scheduled to be studied with transvaginal sonography and hysterosonography, once during their menstrual cycle at periodic intervals. They are also scheduled to have endometrial biopsies as indicated. It is known that all SERMs (clomiphene, tamoxifen and in one small study raloxifene) raise the area under the curve of estradiol levels throughout the cycle in premenopausal women. Our study is designed to study the reproductive effects of raloxifene in these young women with competent ovaries using sonography of the ovaries and endometrium, and correlating it with steroid hormone levels which would be obtained under protocol 98-C-0123.
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Female
Protocol Entry Criteria: Women must be enrolled in NCI Study 98-C-0123.
Total Enrollment: 60

Location and Contact Information:

Warren G. Magnuson Clinical Center (CC)
Bethesda,  Maryland,  20892
United States
 


Additional Information:
Study ID Numbers:  990013;  99-CC-0013
Study Start Date: November 24, 1998
Record last reviewed: November 24, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001837

Other Breast Neoplasm Studies:
1. Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer

2. Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

3. Morbidity after Diagnosis and Treatment of Breast Cancer Patients

4. Comparison of Two Types of Biopsy in Patients With Breast Lesions That Cannot Be Felt Upon Examination

5. A Phase II Study of CI-1033 in Treating Patients with Metastatic (Stage IV) Breast Cancer

Related Studies:

Other Breast Neoplasm Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients
Modify your Search

  Other Breast Neoplasm Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103